Shanrong Biotechnology Corp. (SRBT)
Beverly Hills, CA, US
Shanrong Biotechnology Corp. primarily functions as a provider of executive consulting and project management services. The company specializes in the modernization of armored vehicles, integrating advanced digital communications into their systems. Furthermore, it furnishes critical spare parts and specialized equipment to both military and law enforcement organizations. Beyond hardware provision, its service portfolio also encompasses on-site maintenance, along with comprehensive training programs for maintenance personnel, operators, and tactical operations. Shanrong's expertise additionally extends to program oversight, business expansion initiatives, and strategic analysis within the defense, homeland security, information technology, and telecommunications industries. The entity, formerly known as Defense Solutions Holding, Inc., officially adopted its current name, Shanrong Biotechnology Corp., in September 2017. It is headquartered in Beverly Hills, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | -99.92% | -99.90% | -99.98% | -99.96% | -99.93% | -99.99% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%-43.5% Q4'24: +83.9% (vs Q3'23)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q4'24: +0.8% (vs Q3'23)
-
Share dilution Shell Companies: -10.2%+0.0% ★ Q4'24: +0.0% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×— Q4'24: 0.00× (vs Q3'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Colonel Timothy D. Ringgold | Chief Executive Officer, Director, CEO of Defense Solutions Inc and Director of Defense Solutions Inc | 240.0K | — |
| Gina A. Ringgold | Chief Financial Officer, Secretary & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SRBT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
